Author:
Dalakas Marinos C,Semino-Mora Cristina,Leon-Monzon Marta
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology,Pathology and Forensic Medicine
Reference43 articles.
1. Anderson TD, Davidovich A, Arceo R, Brosnan C, Arezzo J, and Schaumburg H (1992). Peripheral neuropathy induced by 2′3′-dideoxycytidine neurotoxicity. Lab Invest 66: 63–74.
2. Arnaudo E, Dalakas MC, Shanske S, Moraes CT, DiMauro S, and Echon EA (1991). Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 337: 508–510.
3. Benbrik E, Chariot P, Bonavaud S, Ammi-Said M, Frisdal E, Rey C, Gherardi R, and Barlovatz-Meimon G (1997). Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells. J Neurol Sci 149: 19–25.
4. Berger AR, Arezzo JC, Schaumburg HH, Skowron G, Merigan T, Bozzette S, Richman D, and Soo W (1993). 2′3′-dideoxycytidine (ddC) toxic neuropathy: A study of 52 patients. Neurology 43: 358–362.
5. Blum AS, Dal Pan GJ, Feinberg J, Raines C, Mayjo K, Cornblath DR, and McArthur JC (1996). Low-dose zalcitabine-related toxic neuropathy: Frequency, natural history and risk factors. Neurology 46: 999–1003.
Cited by
182 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献